Programme

HOW ARE TECHNOLOGICAL ADVANCES CHANGING THE ECONOMIC INCENTIVES TO GLOBAL HEALTHCARE SYSTEMS?

Managing Disruptions and Embracing Change
Panel Session
Pavilion 5, Conference Hall 5.1


A new generation of mobile monitoring and early diagnostic tools as well as remote treatment platforms could usher in an era focusing on preventive medicine instead of investing predominantly in post-diagnostic treatments. But to accomplish this, both business and public health officials need to work together to adjust incentives and modernize approaches. How pronounced might the shift to preventive healthcare be over the coming years, and how can both governments and businesses capitalize on these changes?


Moderator:
Simon Matskeplishvili , Chairman of the Echocardiography Section, Russian Society of Cardiology; Chief Scientific Researcher, Bakulev Scientific Centre for Cardiovascular Surgery of the Russian Academy of Medical Sciences

Panellists
Olivier Bosc , President, Chief Executive Officer for Russia and CIS, GE Healthcare
Peter Vullinghs , Chief Executive Officer in Russia and the CIS, Philips
Olga Golodets , Deputy Prime Minister of the Russian Federation
Alberto Colzi , Vice-President, Eastern Europe, Middle East, and Africa Operations, AbbVie
Nikolay Pryanishnikov , President, Microsoft in Russia
Vsevolod Rozanov , Senior Vice President, Chief Financial Officer, Sistema
Grigory Roytberg , Chief Executive Officer, Medicina
Paul Stoffels , Worldwide Chairman, Janssen Pharmaceutical Companies of Johnson & Johnson


Kirill Kaem , Vice-President, Executive Director of ВIO Cluster, Skolkovo Foundation
Eero Hautaniemi , President, Chief Executive Officer, Oriola-KD
Sergey Tsyb , Deputy Minister of Industry and Trade of the Russian Federation

Broadcast

Key moments

“Because the most important metric for doctors is a reduced mortality rate, preventative medicine is gradually taking precedence over traditional medicine”.
Simon Matskeplishvili